Literature DB >> 3543911

Bromocriptine, dopamine and glaucoma.

P Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543911      PMCID: PMC2422808          DOI: 10.1136/pgmj.62.731.819

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels.

Authors:  Q A Mekki; S J Warrington; P Turner
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

2.  Ocular effects of selective alpha-adrenergic agents: a new drug paradox?

Authors:  T Mittag
Journal:  Ann Ophthalmol       Date:  1983-03

3.  [Does bromocriptine enhance the effect of drugs that reduce intraocular pressure?].

Authors:  A Lustig
Journal:  Dtsch Med Wochenschr       Date:  1983-10-28       Impact factor: 0.628

4.  Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.

Authors:  Q A Mekki; P Turner
Journal:  Br J Ophthalmol       Date:  1985-12       Impact factor: 4.638

5.  Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.

Authors:  L Z Bito; A Draga; J Blanco; C B Camras
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-03       Impact factor: 4.799

6.  Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.

Authors:  D E Potter; J A Burke; F W Chang
Journal:  Curr Eye Res       Date:  1984-02       Impact factor: 2.424

Review 7.  Ocular effects of beta-adrenergic agents. XII Jules Stein Lecture.

Authors:  S Mishima
Journal:  Surv Ophthalmol       Date:  1982 Nov-Dec       Impact factor: 6.048

8.  Bromocriptine lowers intraocular pressure without affecting blood pressure.

Authors:  Q A Mekki; S M Hassan; P Turner
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

  9 in total
  1 in total

1.  A preliminary study of the ocular hypotensive effects of bromocriptine in diabetic patients with autonomic neuropathy.

Authors:  M R al-Sereiti; P Turner; E A Gale
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.